Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Гипотиреоз

Список литературы

  1. Национальное руководство «Эндокринология» Москва, «Геотар-Медиа», 2016 г; с. с. 604-616, 635-645.
  2. Гарднер Д, Шобек Д. «Базисная и клиническая эндокринология» Москва, Издательство «Бином», 2011 г.; с. 304-364.
  3. Фадеев В.В., Мельниченко Г. А. Гипотиреоз (руководство для врачей). М.: РКИ Соверо пресс, 2002 г., с. 58-112.
  4. Киеня Т.А., Моргунова Т. Б., Фадеев В.В. Вторичный гипотиреоз у взрослых: диагностика и лечение // Клиническая и экспериментальная тиреоидология.  2019; Т. 15; №2: с. 64-72.
  5. Negro R., Formoso G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; N. 91: с. 2587–2591.
  6. Glinoer D., Riahi M., Gru¨n J.P., Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994; N. 79: с. 197–204.
  7. Karmisholt J., Andersen S., Laurberg P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid 2008; N. 18: с. 303–308.
  8. Andersen S., Pedersen K.M., Bruun N.H., Laurberg P. Narrow individual variations in serum T 4 and T 3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; N. 87: с. 1068–1072.
  9. Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012 Jun;97(6):1962-9. doi: 10.1210/jc.2011-3047.
  10. Surks M. I. et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management //Jama. – 2004. – Т. 291. – №. 2. – С. 228-238.
  11. Meyerovitch J, Rotman-Pikielny P, Sherf M, Battat E, Levy Y, Surks MI. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med. 2007 Jul 23;167(14):1533-8. doi: 10.1001/archinte.167.14.1533.
  12. Neumann S., Raaka B.M., Gershengorn M.C. Constitutively active thyrotropin and thyrotropin-releasing hormone receptors and their inverse agonists. Methods Enzymol. 2010; N.485: с. 147-160.
  13. Barbesino G, Sluss PM, Caturegli P: Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis. J Clin Endocrinol Metab 2012; 97: 345–350.
  14. Persani L. Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 2012; N. 97: с. 3068–3078.
  15. Alexopoulou O,Beguin C, De Nayer P, Maiter D. Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol. 2004 Jan;150(1):1-8. doi: 10.1530/eje.0.1500001.
  16. Persani L, Cangiano B, Bonomi M. The diagnosis and management of central hypothyroidism in 2018. Endocr Connect. 2019 Feb;8(2):R44-R54. doi: 10.1530/EC-18-0515.
  17. Grunenwald S., Caron P. Central hypothyroidism in adults: better understanding for better care. Pituitary. 2015; N. 18(1): с. 169-175.
  18. Constine L.S., Woolf P.D., Cann D., Mick G., McCormick K., Raubertas R.F., Rubin P. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993; N. 328(2): с. 87-94.
  19. Snyder P.J., Fowble B.F., Schatz N.J., Savino P.J., Gennarelli T.A. Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med. 1986; N. 81(3): с. 457-462.
  20. Fernandez-Rodriguez E., Bernabeu I., Castro A.I., Casanueva F.F. Hypopituitarism after traumatic brain injury. Endocrinol Metab Clin North Am. 2015; N.44(1): с. 151-159.
  21. Krewer C., Schneider M., Schneider H.J., Kreitschmann-Andermahr I., Buchfelder M., Faust M., Berg C., Wallaschofski H., Renner C., Uhl E., Koenig E., Jordan M., Stalla G.K., Kopczak A.. Neuroendocrine disturbances one to five or more years after traumatic brain injury and aneurysmal subarachnoid hemorrhage: data from the German database on hypopituitarism. J Neurotrauma. 2016; N. 33(16): с. 1544-1553.
  22. Brent G.A. Mechanisms of thyroid hormone action. J Clin Invest. 2012; N. 122(9): с. 3035-3043.
  23. Dow K.H., Ferrell B.R., Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid. 1997; N.7(4): с. 613-619.
  24. Mandel SJ, Brent GA, Larsen PR Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993; N. 119(6): с. 492-502.
  25. Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid. 1995 Aug;5(4):249-53. doi: 10.1089/thy.1995.5.249.
  26. Perez CL, Araki FS, Graf H, de Carvalho GA. Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 2013 Jul;23(7):779-84. doi: 10.1089/thy.2012.0435.
  27. Singh N, Singh PN, Hershman JM Effect of calcium carbonate on the absorption of levothyroxine.JAMA. 2000 Jun 7;283(21):2822-5. doi: 10.1001/jama.283.21.2822.
  28. Ross D.S. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001; N. 30(2): с. 245-264.
  29. Wenzel K.W., Kirschsieper H.E. Aspects of the absorption of oral L-thyroxine in normal man. Metabolism. 1977 Jan;26(1):1-8. doi: 10.1016/0026-0495(77)90121-4.
  30. Woeber K.A.  Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002; Vol. 25(2): с. 106-109.
  31. Benvenga S., Bartolone L., Pappalardo M.A., Russo A., Lapa D., Giorgianni G., Saraceno G., Trimarchi F. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008; N.18(3): с. 293-301.
  32. Liel Y., Harman-Boehm I., Shany S. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab. 1996; N.81(2): с. 857-859.
  33. Perez C.L., Araki F.S., Graf H., de Carvalho G.A. Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 2013; N. 23: с. 779-784.
  34. Zamfirescu I, Carlson HE  Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 2011 May;21(5):483-6. doi: 10.1089/thy.2010.0296. .
  35. Shakir KM, Chute JP, Aprill BS, Lazarus AA Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J. 1997 Jun;90(6):637-9. doi: 10.1097/00007611-199706000-00011.
  36. Mayor G.H., Orlando T., Kurtz N.M. Limitations of Levothyroxine Bioequivalence Evaluation: Analysis of An Attempted Study. American journal of therapeutics Am J Ther. 1995; N. 2(6): с. 417-432.
  37. Eisenberg M., Distefano J.J. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. Thyroid 2009; N. 19(2): c. 103-110.
  38. Biondi B., Palmieri .EA., Lombardi G., Fazio S. Effects of subclinical thyroid dysfunction on the heart // Ann. Intern. Med. 2002. V. 137 P. 904–914.
  39. Paul T.L., Kerrigan J., Kelly A.M. et al. Long-term thyroxine therapy is associated with decreased hip bone density in premenopausal women // JAMA. 1988. V. 259. P. 3137–3141.
  40. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A 2005 The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Archives of internal medicine 165:1714-1720.
  41. He Q, Heo M, Heshka S, Wang J, Pierson RN, Jr., Albu J, Wang Z, Heymsfield SB, Gallagher D 2003 Total body potassium differs by sex and race across the adult age span. The American journal of clinical nutrition 78:72-77.
  42. Taylor PN, Minassian C, Rehman A et al. 2014 TSH levels and risk of miscarriage in women on longterm levothyroxine: a community-based study. J Clin Endocrinol Metab 99:3895–3902.
  43. Alexander EK, Marqusee E, Lawrence J et al. 2004 Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351:241–249.
  44. Yassa L, Marqusee E, Fawcett R, Alexander EK 2010 Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab 95:3234–3241.
  45. Galofre JC, Haber RS, Mitchell AA, et al. 2010 Increased postpartum thyroxine replacement in  Hashimoto’s thyroiditis. Thyroid 20:901–908.
  46. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 2017 Feb;176(2):253-265. doi: 10.1530/EJE-16-0548. .
  47. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. J Clin Endocrinol Metab. 2018 Mar 1;103(3):926-935. doi: 10.1210/jc.2017-01850.
  48. Slawik M, Klawitter B, Meiser E et al. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J Clin Endocrinol Metab 2007; 92: 4115–4122.
  49. Koulouri O, Auldin MA, Agarwal R et al. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Clin Endocrinol 2011; 74: 744–749.
  50. Persani L, Brabant G, Dattani M, et al. European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur Thyroid J 2018 Oct;7(5):225-237. doi: 10.1159/000491388. Epub 2018 Jul 19.
  51. Leger J, Olivieri A, Donaldson M et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr 2014; 81: 80–103.
  52. Agha A, Walker D, Perry L, et al. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf). 2007;66(1):72-77. doi: http://doi.org/10.1111/j.1365-2265.2006.02688.x.
  53. Campbell N. R. C. et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism //Annals of Internal Medicine. – 1992. – Т. 117. – №. 12. – С. 1010-1013.
  54. Persani L., Cangiano B., Bonomi M. The diagnosis and management of central hypothyroidism in 2018 //Endocrine connections. – 2019. – Т. 8. – №. 2. – С. R44-R54.
  55. Raber W. et al. Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects //Thyroid. – 2002. – Т. 12. – №. 8. – С. 725-731.
  56. Pirola I, Gandossi E, Brancato D, et al. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast. J Endocrinol Invest.  - 2018 - – Т. 41. – №. 11 – С. 1301-1306. doi: 10.1007/s40618-018-0867-3.
  57. Carswell JM, Gordon JH, Popovsky E, et al. Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J Clin Endocrinol Metab. 2013 Feb;98(2):610-7. doi: 10.1210/jc.2012-3125
  58. Liu H, Shan Z, Li C, et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid. 2014 Nov;24(11):1642-9. doi: 10.1089/thy.2014.0029.
  59. Strieder TG, Prummel MF, Tijssen JG, et al. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003 Sep;59(3):396-401. doi: 10.1046/j.1365-2265.2003.01862.x.
  60. American Thyroid Association; Endocrine Society; American Association of Clinical Endocrinologists. Joint statement on the U.S. Food and Drug Administration"s decision regarding bioequivalence of levothyroxine sodium. Thyroid. 2004 Jul;14(7):486. doi: 10.1089/1050725041517138.
  61. Fliers E, Demeneix B, Bhaseen A, Brix TH. European Thyroid Association (ETA) and Thyroid Federation International (TFI) Joint Position Statement on the Interchangeability of Levothyroxine Products in EU Countries. Eur Thyroid J. 2018 Oct;7(5):238-242. doi: 10.1159/000493123.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*